Stocks Eli Lilly’s Strong 2Q Underscores the Momentum Behind Its GLP-1 Franchise 7 Aug 20267 Aug 2026 Eli Lilly’s Strong 2Q Underscores the Momentum Behind Its GLP-1 Franchise Eli Lilly’s second-quarter results and another upward revision to 2026 guidance reinforce the strength of its GLP-1 franchise and…
